LC
Lindbrook Capital Portfolio holdings
AUM $1.08B
1-Year Return
10.14%
This Quarter Return
+2.76%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$1.11B
AUM Growth
-$20.5M
(-1.8%)
Cap. Flow
-$106M
Cap. Flow
% of AUM
-9.58%
Top 10 Holdings %
Top 10 Hldgs %
45.22%
Holding
2,969
New
135
Increased
1,006
Reduced
918
Closed
188
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.04M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$1.96M |
| 3 |
Kinder Morgan
KMI
|
+$1.24M |
| 4 |
Blackstone
BX
|
+$962K |
| 5 |
Take-Two Interactive
TTWO
|
+$589K |
Top Sells
| 1 |
Workday
WDAY
|
+$73.6M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.5M |
| 3 |
Golub Capital BDC
GBDC
|
+$6.39M |
| 4 |
Apple
AAPL
|
+$4.01M |
| 5 |
New Mountain Finance
NMFC
|
+$3.65M |
Sector Composition
| 1 | Technology | 17.9% |
| 2 | Financials | 11.68% |
| 3 | Healthcare | 4.7% |
| 4 | Communication Services | 4.55% |
| 5 | Consumer Discretionary | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
951
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $36.3K | ﹤0.01% |
435
+65
| +18% | +$5.43K |
|
952
Ionis Pharmaceuticals
IONS
$9.68B
| $36.2K | ﹤0.01% |
1,036
+671
| +184% | +$23.5K |
|
953
Brixmor Property Group
BRX
$8.59B
| $36.1K | ﹤0.01% |
1,297
| – | – |
|
954
Commercial Metals
CMC
$6.53B
| $36.1K | ﹤0.01% |
727
-30
| -4% | -$1.49K |
|
955
Norwegian Cruise Line
NCLH
$11.8B
| $36K | ﹤0.01% |
1,398
-25
| -2% | -$643 |
|
956
Stride
LRN
$5.99B
| $36K | ﹤0.01% |
346
+10
| +3% | +$1.04K |
|
957
APA Corp
APA
$8.25B
| $36K | ﹤0.01% |
1,557
-483
| -24% | -$11.2K |
|
958
Elanco Animal Health
ELAN
$9.24B
| $35.8K | ﹤0.01% |
2,953
-163
| -5% | -$1.97K |
|
959
Kinross Gold
KGC
$28.3B
| $35.7K | ﹤0.01% |
3,855
+568
| +17% | +$5.27K |
|
960
Enphase Energy
ENPH
$4.99B
| $35.7K | ﹤0.01% |
520
+91
| +21% | +$6.25K |
|
961
Brown & Brown
BRO
$30.2B
| $35.6K | ﹤0.01% |
349
+21
| +6% | +$2.14K |
|
962
Envista
NVST
$3.5B
| $35.6K | ﹤0.01% |
1,843
+125
| +7% | +$2.41K |
|
963
SPDR Portfolio S&P 500 Value ETF
SPYV
$28.3B
| $35.5K | ﹤0.01% |
695
+481
| +225% | +$24.6K |
|
964
BioMarin Pharmaceuticals
BMRN
$10.2B
| $35.4K | ﹤0.01% |
539
+150
| +39% | +$9.86K |
|
965
First Trust Preferred Securities and Income ETF
FPE
$6.21B
| $35.4K | ﹤0.01% |
2,000
| – | – |
|
966
ORIX
IX
$30.1B
| $35.3K | ﹤0.01% |
1,660
| – | – |
|
967
Aramark
ARMK
$9.94B
| $35.2K | ﹤0.01% |
943
+19
| +2% | +$709 |
|
968
CAE Inc
CAE
$8.6B
| $35.1K | ﹤0.01% |
1,382
+390
| +39% | +$9.9K |
|
969
Atkore
ATKR
$2.07B
| $35K | ﹤0.01% |
420
+37
| +10% | +$3.09K |
|
970
TransAlta
TAC
$3.84B
| $34.9K | ﹤0.01% |
2,466
+46
| +2% | +$651 |
|
971
FIVE9
FIVN
$2.01B
| $34.7K | ﹤0.01% |
854
+520
| +156% | +$21.1K |
|
972
Pure Storage
PSTG
$28.4B
| $34.6K | ﹤0.01% |
563
-324
| -37% | -$19.9K |
|
973
Range Resources
RRC
$8.37B
| $34.6K | ﹤0.01% |
961
-154
| -14% | -$5.54K |
|
974
BrightView Holdings
BV
$1.28B
| $34.5K | ﹤0.01% |
2,159
| – | – |
|
975
Byline Bancorp
BY
$1.32B
| $34.5K | ﹤0.01% |
1,190
+46
| +4% | +$1.33K |
|